Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T13:22:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the page, announcing a transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T15:10:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:51:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer now shows site revision v3.7.1 instead of v3.7.0.
    Difference
    0.3%
    Check dated 2026-10-10T14:57:02.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error in place of the clinical study record.
    Difference
    0.2%
    Check dated 2026-10-03T14:50:09.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The study page now presents a 403 Forbidden error instead of the study record, indicating restricted access to the page. The visible content shows a 403 message and site footer, signaling an access issue rather than updated study information.
    Difference
    18%
    Check dated 2026-09-19T18:54:35.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.